Elsevier Publishes First Books in Cell Press Reviews Series
Waltham, MA, December 10, 2013
New book series brings Cell Press journal content on
cell biology, cancer therapeutics and stem cells to researchers without
New book series brings Cell Press journal content on cell biology, cancer therapeutics and stem cells to researchers without institutional access
world-leading provider of scientific, technical and medical information
products and services, today announced the publication of the first titles in
the new Cell Press Reviews book series,
making review content from Cell Press
journals more accessible to researchers without institutional access and to others
interested in learning more about the topics at a high level. The first book to
publish, Cell Press Reviews: Core Concepts in Cell
Biology, will be presented at the upcoming American Society for Cell Biology annual
meeting in New Orleans, LA, December 14–18, Booth #224.
"We are delighted to present these high-impact, comprehensive reviews in book format for the first time," said Emilie Marcus, CEO of Cell Press and Editor of Cell. "Our editorial team carefully selected review articles that not only provide an overview of recent advances in these fields, but also look to what is coming next in these areas."
Cell Press's in-house journal editors, who are subject-matter experts, curated the high-quality, high-impact journal review articles into accessible books on the current state and future direction of cell biology, cancer therapeutics and stem cells to model and treat disease.
"Nothing beats a book of high-quality review articles to provide a researcher with timely, comprehensive coverage of a topic," said Suzanne BeDell, Managing Director, Science and Technology Books at Elsevier. "Working together with Cell Press to make its definitive reviews available in book form supports our ongoing goal to offer high-quality content that makes researchers, students, educators and practitioners more productive."
The books in the series, published under the AP Cell imprint, include:
- Cell Press Reviews: Core Concepts in Cell Biology
- Cell Press Reviews: Stem Cells to Model and Treat Disease
- Cell Press Reviews: Cancer Therapeutics
The books are available on the Elsevier Store and through other online book retailers.
# # #
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and 25,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Publicity Manager, Science & Technology Books
+1 781 663 2268